Natural antibodies against nerve growth factor inhibit in vitro prostate cancer cell metastasis

Cancer Immunology, Immunotherapy

Volumn 60, Issue 2, 2011, Pages 187-195

  Warrington, Richard J ^a   Lewis, Keith E ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Anti NGF effects; IVIg; NGF; Prostate cancer cell invasion

Indexed keywords

IMMUNOGLOBULIN; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; NERVE GROWTH FACTOR; NERVE GROWTH FACTOR ANTIBODY;

ANTIBODY SPECIFICITY; ARTICLE; CANCER CELL CULTURE; CELL DIFFERENTIATION; CELL MIGRATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; INHIBITION KINETICS; MALE; METASTASIS INHIBITION; PRIORITY JOURNAL; PROSTATE CANCER;

CELL MOVEMENT; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MALE; NEOPLASM METASTASIS; NERVE GROWTH FACTOR; PROSTATIC NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 79151472084     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-010-0934-x     Document Type: Article

References (52)

1. A Jemal R Siegel E Ward Y Hao J Xu MJ Thun 2009 Cancer statistics CA Cancer J Clin 59 4 225 249 10.3322/caac.20006 19474385
2. Z Culig A Hobisch MV Cronauer, et al. 1996 Regulation of prostatic growth and function by peptide growth factors Prostate 28 6 392 405 1:CAS:528:DyaK28XksVOntbg%3D 10.1002/(SICI)1097-0045(199606)28:6<392::AID- PROS9>3.0.CO;2-C 8650077
3. RD Bonfil S Chinni R Fridman HR Kim ML Cher 2007 Proteases, growth factors, chemokines, and the microenvironment in prostate cancer bone metastasis Urol Oncol 25 5 407 411 1:CAS:528:DC%2BD2sXhtVWhtr3M 17826661
4. K Jacob M Webber D Benayahu HK Kleinman 1999 Osteonectin promotes prostate cancer cell migration and invasion: a possible mechanism for metastasis to bone Cancer Res 59 17 4453 4457 1:CAS:528:DyaK1MXlvVSmsbg%3D 10485497
5. A Angelucci C Festuccia G D'Andrea A Teti M Bologna 2002 Osteopontin modulates prostate carcinoma invasive capacity through RGD-dependent upregulation of plasminogen activators Biol Chem 383 1 229 234 1:CAS:528:DC%2BD38XivV2htr0%3D 10.1515/BC.2002.024 11928818
6. GO Hellawell GD Turner DR Davies R Poulsom SF Brewster VM Macaulay 2002 Expression of the type 1 insulin-like growth factor receptor is up-regulated in primary prostate cancer and commonly persists in metastatic disease Cancer Res 62 10 2942 2950 1:CAS:528:DC%2BD38XjvFSmtLg%3D 12019176
7. CA Heinlein C Chang 2004 Androgen receptor in prostate cancer Endocr Rev 25 2 276 308 1:CAS:528:DC%2BD2cXktFSqtLY%3D 10.1210/er.2002-0032 15082523
8. SR Chinni S Sivalogan Z Dong JC Filho X Deng RD Bonfil ML Cher 2006 CXCL12/CXCR4 signaling activates Akt-1 and MMP-9 expression in prostate cancer cells: the role of bone microenvironment-associated CXCL12 Prostate 66 1 32 48 1:CAS:528:DC%2BD28XmsFehtw%3D%3D 10.1002/pros.20318 16114056
9. Y Luo DL He L Ning, et al. 2006 Over-expression of hypoxia-inducible factor-1alpha increases the invasive potency of LNCaP cells in vitro BJU Int 98 6 1315 1319 1:CAS:528:DC%2BD2sXktlarsA%3D%3D 10.1111/j.1464-410X.2006.06480.x 16956360
10. A Lambiase A Micera R Sgrulletta S Bonini S Bonini 2004 Nerve growth factor and the immune system: old and new concepts in the cross-talk between immune and resident cells during pathophysiological conditions Curr Opin Allergy Clin Immunol 4 5 425 430 1:CAS:528:DC%2BD2cXpt1Glur0%3D 10.1097/00130832- 200410000-00015 15349043
11. M Tometten S Blois PC Arck 2005 Nerve growth factor in reproductive biology: link between the immune, endocrine and nervous system? Chem Immunol Allergy 89 135 148 1:CAS:528:DC%2BD2MXht1eiu7bN 10.1159/000087962 16129960
12. WA Nockher H Renz 2006 Neurotrophins in allergic diseases: from neuronal growth factors to intercellular signaling molecules J Allergy Clin Immunol 117 3 583 589 1:CAS:528:DC%2BD28Xit1aqt7c%3D 10.1016/j.jaci.2005.11.049 16522457
13. WA Nockher H Renz 2006 Neurotrophins and asthma: novel insight into neuroimmune interaction J Allergy Clin Immunol 117 1 67 71 1:CAS:528: DC%2BD28Xktlah 10.1016/j.jaci.2005.08.029 16387586
14. R Linker R Gold F Luhder 2009 Function of neurotrophic factors beyond the nervous system: inflammation and autoimmune demyelination Crit Rev Immunol 29 1 43 68 1:CAS:528:DC%2BD1MXmtVSrs78%3D 19348610
15. M Abram M Wegmann V Fokuhl, et al. 2009 Nerve growth factor and neurotrophin-3 mediate survival of pulmonary plasma cells during the allergic airway inflammation J Immunol 182 8 4705 4712 1:CAS:528:DC%2BD1MXjvFOjtb8%3D 10.4049/jimmunol.0802814 19342646
16. A Krüttgen I Schneider J Weis 2006 The dark side of the NGF family: neurotrophins in neoplasias Brain Pathol 16 4 304 310 10.1111/j.1750-3639.2006. 00037.x 17107600
17. AG Papatsoris D Liolitsa C Deliveliotis 2007 Manipulation of the nerve growth factor network in prostate cancer Expert Opin Investig Drugs 16 3 303 309 1:CAS:528:DC%2BD2sXhvVSht7g%3D 10.1517/13543784.16.3.303 17302525 Review
18. D Djakiew R Delsite B Pflug J Wrathall JH Lynch M Onoda 1991 Regulation of growth by a nerve growth factor-like protein which modulates paracrine interactions between a neoplastic epithelial cell line and stromal cells of the human prostate Cancer Res 51 12 3304 3310 1:CAS:528:DyaK3MXksVOjsrk%3D 1710170
19. R Delsite D Djakiew 1999 Characterization of nerve growth factor precursor protein expression by human prostate stromal cells: a role in selective neurotrophin stimulation of prostate epithelial cell growth Prostate 41 1 39 48 1:CAS:528:DyaK1MXlvFaksb4%3D 10.1002/(SICI)1097-0045(19990915)41: 1<39::AID-PROS6>3.0.CO;2-E 10440874
20. R Dalal D Djakiew 1997 Molecular characterization of neurotrophin expression and the corresponding tropomyosin receptor kinases (trks) in epithelial and stromal cells of the human prostate Mol Cell Endocrinol 134 1 15 22 1:CAS:528:DyaK2sXntVOrurw%3D 10.1016/S0303-7207(97)00165-2 9406845
21. BR Pflug C Dionne DR Kaplan J Lynch D Djakiew 1995 Expression of a Trk high affinity nerve growth factor receptor in the human prostate Endocrinology 136 1 262 268 1:CAS:528:DyaK2MXjt1KntLk%3D 10.1210/en.136.1.262 7828539
22. BR Pflug M Onoda JH Lynch D Djakiew 1992 Reduced expression of the low affinity nerve growth factor receptor in benign and malignant human prostate tissue and loss of expression in four human metastatic prostate tumor cell lines Cancer Res 52 19 5403 5406 1:CAS:528:DyaK38XmsV2gsrg%3D 1382843
23. AA Geldof MA De Kleijn BR Rao DW Newling 1997 Nerve growth factor stimulates in vitro invasive capacity of DU145 human prostatic cancer cells J Cancer Res Clin Oncol 123 2 107 112 1:CAS:528:DyaK2sXntFyktA%3D%3D 10.1007/BF01269888 9030249
24. ET Walch D Marchetti 1999 Role of neurotrophins and neurotrophins receptors in the in vitro invasion and heparanase production of human prostate cancer cells Clin Exp Metastasis 17 4 307 314 1:CAS:528:DyaK1MXnsVWhsLo%3D 10.1023/A:1006652605568 10545017
25. S Krygier D Djakiew 2001 Molecular characterization of the loss of p75(NTR) expression in human prostate tumor cells Mol Carcinog 31 1 46 55 1:CAS:528:DC%2BD3MXktlOku74%3D 10.1002/mc.1038 11398197
26. S Krygier D Djakiew 2002 Neurotrophin receptor p75(NTR) suppresses growth and nerve growth factor-mediated metastasis of human prostate cancer cells Int J Cancer 98 1 1 7 1:CAS:528:DC%2BD38Xht1WgsLw%3D 10.1002/ijc.10160 11857376
27. C Festuccia P Muzi GL Gravina, et al. 2007 Tyrosine kinase inhibitor CEP-701 blocks the NTRK1/NGF receptor and limits the invasive capability of prostate cancer cells in vitro Int J Oncol 30 1 193 200 1:CAS:528: DC%2BD2sXhtFyrtbg%3D 17143529
28. RJ Warrington KE Lewis 2007 Biologically active anti-nerve growth factor antibodies in commercial intravenous gammaglobulin J Autoimmun 28 1 24 29 1:CAS:528:DC%2BD2sXit1GrsLo%3D 10.1016/j.jaut.2006.11.005 17218083
29. KG Halvorson K Kubota MA Sevcik, et al. 2005 A blocking antibody to nerve growth factor attenuates skeletal pain induced by prostate tumor cells growing in bone Cancer Res 65 20 9426 9435 1:CAS:528:DC%2BD2MXhtFWmu73J 10.1158/0008-5472.CAN-05-0826 16230406
30. SJ Miknyoczki W Wan H Chang, et al. 2002 The neurotrophin-trk receptor axes are critical for the growth, progression of human prostatic carcinoma, pancreatic ductal adenocarcinoma xenografts in nude mice Clin Cancer Res 8 6 1924 1931 1:CAS:528:DC%2BD38Xlt1Crurk%3D 12060637
31. J Schachter U Katz A Mahrer, et al. 2007 Efficacy and safety of intravenous immunoglobulin in patients with metastatic melanoma Ann N Y Acad Sci 1110 305 314 1:CAS:528:DC%2BD2sXht1Git7jL 10.1196/annals.1423.032 17911445
32. M Damianovich AS Solomon M Blank Y Shoenfeld 2007 Attenuation of colon carcinoma tumor spread by intravenous immunoglobulin Ann N Y Acad Sci 1110 567 577 1:CAS:528:DC%2BD2sXht1GitL%2FF 10.1196/annals.1423.061 17911473
33. P Fishman S Bar-Yehuda Y Shoenfeld 2002 IVIg to prevent tumor metastases Int J Oncol 21 4 875 880 1:CAS:528:DC%2BD38XotFKitbs%3D 12239629
34. D Muir L Sukhu J Johnson MA Lahorra BL Maria 1993 Quantitative methods for scoring cell migration and invasion in filter-based assays Anal Biochem 215 1 104 109 1:CAS:528:DyaK2cXis12ltQ%3D%3D 10.1006/abio.1993.1561 8297001
35. K Saito T Oku N Ata H Miyashiro M Hattori I Saiki 1997 A modified and convenient method for assessing tumor cell invasion and migration and its application to screening inhibitors Biol Pharm Bull 20 4 345 348 1:CAS:528:DyaK2sXislahtb0%3D 9145207
36. P Wood 2009 Primary antibody deficiency syndromes Ann Clin Biochem 46 Pt 2 99 108 1:CAS:528:DC%2BD1MXktlOqu7w%3D 10.1258/acb.2008.008175 19151170
37. K Darabi O Abdel-Wahab WH Dzik 2006 Current usage of intravenous immune globulin and the rationale behind it: the Massachusetts General Hospital data and a review of the literature Transfusion 46 5 741 753 1:CAS:528: DC%2BD28XltFajtr0%3D 10.1111/j.1537-2995.2006.00792.x 16686841
38. S Graff-Dubois S Sibéril S Elluru, et al. 2007 Use of intravenous polyclonal immunoglobulins in autoimmune and inflammatory disorders Transfus Clin Biol 14 1 63 68 10.1016/j.tracli.2007.04.003 17498995
39. C Galeotti MS Maddur MD Kazatchkine L Mouthon SV Kaveri 2009 Mechanisms of action of IVIG in autoimmune and inflammatory disorders: Recent developments Transfus Clin Biol 16 2 75 79 1:STN:280:DC%2BD1MvnsVyktg%3D%3D 10.1016/j.tracli.2009.03.009 19443254
40. L Sarti T Falai F Pinto E Tendi S Matà 2009 Intravenous immune globulin usage for neurological and neuromuscular disorders: an academic centre, 4 years experience Neurol Sci 30 3 213 218 10.1007/s10072-009-0043-9 19259617
41. X Wang JH Bauer Y Li, et al. 2001 Characterization of a p75(NTR) apoptotic signaling pathway using a novel cellular model J Biol Chem 276 36 33812 33820 1:CAS:528:DC%2BD3MXmslyltrc%3D 10.1074/jbc.M010548200 11451944
42. S Rabizadeh DE Bredesen 2003 Ten years on: mediation of cell death by the common neurotrophin receptor p75(NTR) Cytokine Growth Factor Rev 14 3-4 225 239 1:CAS:528:DC%2BD3sXkt1Ghsrg%3D 10.1016/S1359-6101(03)00018-2 12787561
43. F Khwaja A Tabassum J Allen D Djakiew 2006 The p75(NTR) tumor suppressor induces cell cycle arrest facilitating caspase mediated apoptosis in prostate tumor cells Biochem Biophys Res Commun 341 4 1184 1192 1:CAS:528: DC%2BD28Xhs1Wmsbg%3D 10.1016/j.bbrc.2006.01.073 16460673
44. S Giraud C Lautrette B Bessette C Decourt M Mathonnet MO Jauberteau 2005 Modulation of Fas-induced apoptosis by p75 neurotrophin receptor in a human neuroblastoma cell line Apoptosis 10 6 1271 1283 1:CAS:528: DC%2BD28XmsFCrtQ%3D%3D 10.1007/s10495-005-2649-6 16215672
45. AT Weeraratna JT Arnold DJ George A DeMarzo JT Isaacs 2001 Rational basis for Trk inhibition therapy for prostate cancer Prostate 45 2 140 148 10.1002/1097-0045(20001001)45:2<140::AID-PROS8>3.0.CO;2-#
46. S Sigala N Tognazzi MC Rizzetti I Farzoni C Missale E Bonmassar P Spano 2002 Nerve growth factor induces the re-expression of functional androgen receptors and p75(NGFR) in the androgen-insensitive prostate cancer cell line DU145 Eur J Endocrinol 147 3 407 415 1:CAS:528:DC%2BD38XpsVOlu7s%3D 10.1530/eje.0.1470407 12213679
47. S Sigala I Faraoni D Botticini M Paez-Pereda C Missale E Bonmassar P Spano 1999 Suppression of telomerase, re-expression of KA11, and abrogation of tumorigenicity by nerve growth factor in Prostate Cancer cell lines Clin Cancer Res 5 1211 1218 1:CAS:528:DyaK1MXjslKltb0%3D 10353759
48. D Djakiew BR Pflug R Delsite M Onoda JH Lynch G Arand EW Thompson 1993 Chemotaxis and chemokinesis of human prostate tumor cell lines in response to human prostate stromal cell secretory products containing a nerve growth factor-like protein Cancer Res 53 6 1416 1420 1:CAS:528:DyaK3sXitlWgtLk%3D 8443820
49. R Delsite D Djakiew 1996 Anti-proliferative effect of the kinase inhibitor K252a on human prostatic carcinoma cell lines J Androl 17 5 481 490 1:CAS:528:DyaK2sXitlKlsg%3D%3D 8957691
50. FP Fraser V Salvador EA Manning J Mizal S Alfun M Raza RJ Berridge MB Djamgoz 2003 Contribution of functional voltage-gated Na+ channel expression to cell behaviors involved in the metastatic cascade in rat cancer J Cell Physiol 195 3 479 487 1:CAS:528:DC%2BD3sXjs1yhsLg%3D 10.1002/jcp.10312 12704658
51. JK Diss D Stewart F Pani MM Walker A Patel MB Djamgoz 2005 A potential novel marker for human prostate cancer: voltage-gated sodium channel expression in vivo Prostate Cancer Prostatic Dis 8 3 266 273 1:CAS:528:DC%2BD2MXpslalt7w%3D 10.1038/sj.pcan.4500796 16088330
52. WT Brackenbury MB Djamgoz 2007 Nerve growth factor enhances voltage-gated Nat channel activity and transwell migration in Mat-LyLu rat prostate cancer cell line J Cell Physiol 210 3 602 608 1:CAS:528:DC%2BD2sXht1ejtbs%3D 10.1002/jcp.20846 17149708